Additionally, significant activation of the tumor necrosis factor-alpha (TNF-α)/nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway has been observed in patients with favorable HIPEC responses, suggesting a key role in tumor sensitization to subsequent chemotherapy. Here, TNF is linked to neoplasm.